A review on mechanism of action, resistance, synergism, and clinical implications of mupirocin against Staphylococcus aureus - 09/12/18
, Arezoo Asadi c, Saleh Soleimani d, Moloudsadat Motahar a, b, Mohammad Savari a, e, Morteza Saki a, b, Mahtab Abdi a, bBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 10 |
| Iconographies | 5 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Mupirocin (MUP), bactroban, or pseudomonic acid is a natural crotonic acid derivative drug extracted from Pseudomonas fluorescens which is produced by modular polyketide synthases.
This antibiotic has a unique chemical structure and mechanism of action. It is a mixture of A–D pseudomonic acids and inhibits protein synthesis through binding to bacterial isoleucyl-tRNA synthetase.
MUP is often prescribed to prevent skin and soft tissue infections caused by S. aureus isolates and where the MRSA isolates are epidemic, MUP may be used as a choice drug for nasal decolonization. It is also used for prevention of recurring infections and control the outbreaks.
The emergence of MUP resistance has been increasing particularly among methicillin-resistant Staphylococcus aureus (MRSA) isolates in many parts of the world and such resistance is often related with MUP widespread uses. Although both low-level and high-level MUP resistance were reported among MRSA isolates, the rate of resistance is different in various geographic areas.
In this review, we will report the global prevalence of MUP resistance, discuss synergism and mechanism of action of MUP, and provide new insights into the clinical use of this antibiotic.
Le texte complet de cet article est disponible en PDF.Keywords : Staphylococcus aureus, Mupirocin, Resistance, MRSA, Global prevalence
Plan
Vol 109
P. 1809-1818 - janvier 2019 Retour au numéro
Article précédent
- Molecular modulators of celastrol as the keystones for its diverse pharmacological activities
- Sin Wi Ng, Yinghan Chan, Dinesh Kumar Chellappan, Thiagarajan Madheswaran, Farrukh Zeeshan, Yik Lung Chan, Trudi Collet, Gaurav Gupta, Brian G. Oliver, Peter Wark, Nicole Hansbro, Alan Hsu, Philip Michael Hansbro, Kamal Dua, Jithendra Panneerselvam
- A novel hypertensive crisis rat model established by excessive norepinephrine infusion and the potential therapeutic effects of Rho-kinase inhibitors on it
- Tian-Yi Yuan, Di Chen, Yu-Cai Chen, Hui-Fang Zhang, Zi-Ran Niu, Xiao-Zhen Jiao, Ping Xie, Lian-Hua Fang, Guan-Hua Du
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?